BLES Biochemicals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8-60 Pacific Ct, London, Ontario, N5V 3K...Phone Number
(519) 457-2537Website
www.blesbiochem.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About BLES Biochemicals
BLES Biochemicals Inc. is an established global player in providing innovative solutions for treating NRDS. With over 40 years of research and the development of BLES®, the leading pulmonary surfactant in Canada4, and now BLEScathTM , the company strives to provide interventions that expand the standard of care practices. The company's researchers aim to complement existing practices and enhance neonatal care to alleviate NRDS-related mortality and morbidity. Many premature infants with NRDS may not have survived without treatment with an exogenous pulmonary surfactant, such as BLES®. The company believes that everyone deserves access to this therapy, and the company works hard to make that a reality around the world. The innovation of BLEScathTM results from a continued commitment to that mission. The company want to live in a world where every neonate with NRDS has access to life-saving pulmonary surfactant and associated delivery devices. Until this vision is realized, the company cRead more
BLES Biochemicals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BLES Biochemicals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when BLES Biochemicals launches new products
BLES Biochemicals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once BLES Biochemicals has new funding data
Check if BLES Biochemicals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BLES Biochemicals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if BLES Biochemicals is spiking on competitors!
Click to see if BLES Biochemicals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at BLES Biochemicals
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to BLES Biochemicals
Compare insights from companies similar to BLES Biochemicals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BLES Biochemicals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BLES Biochemicals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BLES Biochemicals.
BLES Biochemicals Tech Stack
A closer look at the technologies used by BLES Biochemicals
BLES Biochemicals News & Media
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding BLES Biochemicals
Sign Up For FreeTo access detailed company insights
BLES Biochemicals Inc. is an established global player in providing innovative solutions for treating NRDS. With over 40 years of research and the development of BLES®, the leading pulmonary surfactant in Canada4, and now BLEScathTM , the company strives to provide interventions that expand the standard of care practices. The company's researchers... Read More
